0001093557-16-000691.txt : 20160913 0001093557-16-000691.hdr.sgml : 20160913 20160913203052 ACCESSION NUMBER: 0001093557-16-000691 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160909 FILED AS OF DATE: 20160913 DATE AS OF CHANGE: 20160913 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VALDES JORGE A CENTRAL INDEX KEY: 0001343856 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 161883987 MAIL ADDRESS: STREET 1: C/O DEXCOM INC STREET 2: 5555 OBERLIN DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2016-09-09 0 0001093557 DEXCOM INC DXCM 0001343856 VALDES JORGE A 6340 SEQUENCE DRIVE SAN DIEGO CA 92121 0 1 0 0 CTO Common Stock 2016-09-09 4 M 0 12000.0 7.63 A 103667 D Common Stock 2016-09-09 4 S 0 12000.0 93.6591 D 91667 D Common Stock 2016-09-09 4 J 0 11833.0 95.8 D 79834 D Common Stock 2016-09-09 4 J 0 7500.0 95.8 D 72334 D Common Stock 2016-09-09 4 J 0 11833.0 95.8 A 13383 I by Trust Common Stock 2016-09-09 4 J 0 7500.0 95.8 A 20883 I by Trust Common Stock 2016-09-09 4 D 0 6312.0 93.7227 D 14571 I by Trust Common Stock 2016-09-09 4 D 0 4001.0 93.7226 D 10570 I by Trust Common Stock 2016-09-12 4 S 0 7071.0 92.0612 D 3499 I by Trust Non-Qualified Stock Option (right to buy) 7.63 2016-09-09 4 M 0 12000.0 93.6591 D 2009-05-19 2018-05-19 Common Stock 12000 13583 D On March 7, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. This transaction was executed in multiple trades at prices ranging from $92.85 to $94.98. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest on March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Shares were transferred from direct ownership to ownership under the Valdes-Lopez-Calleja Family Trust upon vesting of previously awarded restricted stock units. Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee. These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. This transaction was executed in multiple trades at prices ranging from $92.06 to $92.07. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. CONFIRMING STATEMENT: This Statement confirms that the undersigned Jorge Valdes, has authorized and designated Steve Pacelli, Jess Roper, Kevin Sun, Patrick Murphy and Timothy O'Brien to execute and file on the undersigned's behalf all Forms 3, 4, and 5 (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned's ownership of or transactions in securities of DexCom, Inc. The authority of Steve Pacelli, Jess Roper, Kevin Sun, Patrick Murphy and Timothy O'Brien under this Statement shall continue until the undersigned is no longer required to file Forms 3, 4, and 5 with regard to the undersigned's ownership of or transactions in securities of DexCom, Inc., unless earlier revoked in writing. The undersigned acknowledges that Steve Pacelli, Jess Roper, Kevin Sun, Patrick Murphy and Timothy O'Brien are not assuming any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. Date: August 25, 2016 /s/ JORGE VALDES Jorge Valdes By: Kevin Sun For: Jorge Valdes 2016-09-13